Navigation Links
Should men at risk for cardiovascular disease receive earlier cholesterol treatment?
Date:7/22/2014

New Rochelle, NY -- New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic cardiovascular disease or of having a heart attack or stroke as do women with a similar risk profile (based on age, smoking history, and cholesterol and blood pressure levels). The implications of this finding for when and how aggressively to treat high cholesterol are examined in an Editorial in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Men's Health website at http://online.liebertpub.com/doi/full/10.1089/jomh.2014.1500 until August 22, 2014.

Stephen L. Kopecky, MD, Mayo Clinic, Rochester, MN, and Ajay Nehra, MD, Rush University Medical Center, Chicago, IL, discuss the risk factors on which the American College of Cardiology and the American Heart Association based their new guidelines. They describe the value in developing 10-year risk and lifetime risk estimates and their use in educating patients and encouraging lifestyle changes. The authors note the omission of erectile dysfunction as a risk marker, and they explain the new cholesterol treatment recommendations in the Editorial entitled "Cardiovascular Risk and Cholesterol Management in Men: Implications of the New Guidelines."


'/>"/>
Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related medicine news :

1. Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why”
2. New NAT Study is Good News for Anyone with Medium-to-Severe Shoulder Pain
3. Adults with eosinophilic esophagitis should consider a diet change
4. Little League Shoulder on the Rise
5. Shoulder Fired Anti Tank Market Estimated to Reach $3.2 Billion by 2020 – New Report by MarketsandMarkets
6. The Lancet Neurology: Post-concussion return to play decision for footballers should be made solely by doctors, says new editorial
7. Stabilizing Shoulder Surgery Helps NFL Players Return to the Game
8. Intercollegiate Contact Athletes with Shoulder Instability Return to In-Season Sports, Study Shows
9. Shoulder Surgery Gets NFL Players Back in the Game
10. Nutrition screenings should be regular part of geriatric health assessment
11. Quick, easy, inexpensive cortisol testing should soon be available on all smartphones
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Should men at risk for cardiovascular disease receive earlier cholesterol treatment?
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: